Molecular screening of consecutive breast and ovarian cancer patients revealed that 3.77% of breast cancer and 9.9% of ovarian cancer patients had been harboring one of the BRCA1 founder mutations [2]. The gene discussed is BRCA1; the disease is ovarian carcinoma.